KCPG
ONCS

Kavar Capital Partners Group’s OncoSec Medical Incorporated ONCS Stock Holding History

Kavar Capital Partners Group’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-5
Closed -$1K – 441
2018
Q2 		$1K Buy
+5
New +$1.75K ﹤0.01% 442

Other funds holding ONCS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Kavar Capital Partners Group's ONCS Position: Q3 2018 in Review

Kavar Capital Partners Group sold out of OncoSec Medical Incorporated (ONCS) in Q3 2018, closing a stake of 5 shares — an estimated $1K sold.

Kavar Capital Partners Group first reported a position in ONCS in Q2 2018 and held it in 1 quarter. The position peaked at $1K in Q2 2018. 32 funds tracked by Wall St. Rank hold ONCS as of Q3 2018.

  • Kavar Capital Partners Group reported no remaining OncoSec Medical Incorporated position as of Q3 2018 after selling out during the quarter.
  • Kavar Capital Partners Group sold 5 OncoSec Medical Incorporated shares in Q3 2018, an estimated $1K.
  • Kavar Capital Partners Group first reported a position in OncoSec Medical Incorporated in Q2 2018 and held it in 1 quarter.
  • Kavar Capital Partners Group's OncoSec Medical Incorporated position peaked at $1K in Q2 2018.
  • 32 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q3 2018.

Based on Kavar Capital Partners Group's 13F filing for Q3 2018, filed 9 Nov 2018.